McBride K, Nemer M
Laboratoire de développement et différenciation cardiaques, Institut de recherches cliniques de Montréal, QC, Canada.
Can J Physiol Pharmacol. 2001 Aug;79(8):673-81.
The identification and molecular cloning of the cardiac transcription factors GATA-4, -5, and -6 has greatly contributed to our understanding of how tissue-specific transcription is achieved during cardiac growth and development. Through analysis of their interacting partners, it has also become apparent that a major mechanism underlying spatial and temporal specificity within the heart as well as in the response to cardiogenic regulators is the combinatorial interaction between cardiac-restricted and inducible transcription factors. The cardiac GATA factors appear to be fundamental contributors to these regulatory networks. Two of the first targets identified for the cardiac GATA factors were the natriuretic peptide genes encoding atrial natriuretic factor (ANF) and B-type natriuretic peptide (BNP), the major heart secretory products that are also accepted clinical markers of the diseased heart. Studies using the ANF and BNP promoters as models of cardiac-specific transcription have unraveled the pivotal role that GATA proteins play in cardiac gene expression. We review the current knowledge on the modulation of the natriuretic peptide promoters by GATA factors, including examples of combinatorial interactions between GATA proteins and diverse transcription factors.
心脏转录因子GATA-4、-5和-6的鉴定与分子克隆,极大地促进了我们对心脏生长发育过程中组织特异性转录实现方式的理解。通过对其相互作用伙伴的分析,还明显发现,心脏内时空特异性以及对心脏发生调节因子反应的一个主要机制,是心脏限制性转录因子与诱导性转录因子之间的组合相互作用。心脏GATA因子似乎是这些调控网络的基本贡献者。最初确定的心脏GATA因子的两个靶标是编码心房利钠因子(ANF)和B型利钠肽(BNP)的利钠肽基因,这两种物质是心脏的主要分泌产物,也是公认的患病心脏的临床标志物。以ANF和BNP启动子作为心脏特异性转录模型的研究,揭示了GATA蛋白在心脏基因表达中所起的关键作用。我们综述了目前关于GATA因子对利钠肽启动子调控的认识,包括GATA蛋白与多种转录因子之间组合相互作用的实例。